All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

Emerging Trends in the Pharma Industry: Drug Development, Sustainability, and Digitalization

June 7, 2023
By BASF
Webcast

Webcasts

Webinar Date/Time: Tuesday, June 27th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT Wednesday, June 28th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT Thursday, June 29th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

PharmTech and BASF Pharma Solutions are pleased to present a new virtual mini-conference addressing the topics and emerging trends across the pharma industry.

Register Free: https://www.pharmtech.com/pt_w/emerging-trends

Event Overview:

PharmTech and BASF Pharma Solutions are pleased to present a new virtual mini-conference addressing the topics and emerging trends across the pharma industry.


Each day of the conference features dynamic keynote speakers and presentations from industry leaders in the fields of drug development and formulations for patient compliance and convenience, partnerships with CDMOs/CMOs, digitalization in quality and regulatory and new perspectives on sustainability.


This conference is offered free of charge to attendees thanks to event sponsor BASF Pharma Solutions. Join us for the sessions that most interest you – or join for the entire conference!


Who Should Attend
The conference covers a range of topics across the pharma industry that will be interesting to:

  • Those working with or interested in drug development and formulations
  • Those working with or interested in digitalization topics such as machine learning
  • Those working with or interested in quality and regulatory
  • Those working with or interested in sustainability

DAY 1, June 27: Formulations for Patient Compliance and Convenience
Moderator: Jill Murphy, Editor of Pharmaceutical Technology

DAY 2, June 28: Partnerships: CDMO/CMO, Digitalization
Moderator: Feliza Mirasol, Editor of Pharmaceutical Technology

DAY 3, June 29: Perspectives on Sustainability in the Pharmaceutical Industry
Moderator: Felicity Thomas, Senior Editor of Pharmaceutical Technology

Event Agenda:

DAY ONE: Tuesday, June 27th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Formulations for Patient Compliance and Convenience

8:00-8:45 am EDT
Keynote Presentation: Patient-centricity/Compliance/Convenience
Dr. Stephen W. Hoag, Professor, Department of Pharmaceutical Sciences; University of Maryland

9:00-9:45 am EDT
The New Frontiers of Amorphous Solid Dispersions
Lindsay Johnson, PhD, Global Technical Marketing Manager; BASF Pharma Solutions
(Q&A – 5 min)

10:00-10:45 am EDT
Pediatric Taste Masking
Dr Catherine Tuleu, Professor in Pediatric Pharmaceutics; UCL School of Pharmacy
(Q&A – 5 min)

11:00-11:45 am EDT
Taste Masking
Joao Assis, MSc, Global Technical Marketing Manager; BASF Pharma Solutions
(Q&A – 5 min)


DAY TWO: Wednesday, June 28th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Partnerships: CDMO/CMO, Digitalization

8:00-8:45 am EDT
Keynote Presentation: Partnerships and/or Digitalization in Pharma
Toni Manzano, co-founder and CSO; Aizon
(Q&A – 5 min)

9:00-9:45 am EDT
CDMOs – Enabling Tech Decisions
Lindsay Johnson, PhD, Global Technical Marketing Manager; BASF Pharma Solutions
(Q&A – 5 min)

10:00-10:45 am EDT
CDMOs – QbD
Speaker TBA
(Q&A – 5 min)

11:00-12:00 pm EDT
Panel discussion: Digitalization in Quality & Regulatory
Dominick Odenbach; BASF Pharma Solutions
Marius Stoffels; Merck KgaA, Darmstadt, Germany

Moderated by Feliza Mirasol


DAY THREE: Thursday, June 29th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Perspectives on Sustainability in the Pharmaceutical Industry

8:00-8:45 am EDT
Keynote Presentation: Sustainability
Speaker TBA

9:00-9:45 am EDT
Panel discussion: Sustainability Across the Value Chain
Bailey Risteen, PhD; BASF Pharma Solutions
Hanns-Christian Mahler, CEO; Ten23 Health
Sebastien Taillemite, President; Ecovamed

Moderated by Felicity Thomas

10:00-10:45 am EDT
Continuous Manufacturing
Joao Assis, MSc, Global Technical Marketing Manager; BASF Pharma Solutions
Dr. Fernando Muzzio, Distinguished Professor, Chemical and Biochemical Engineering; Rutgers University
(Q&A – 5 min)

11:00-11:45 am EDT
Eco-Design
Will Clark, Senior Director, CMC Sustainability; GSK
(Q&A – 5 min)

Speakers:

Joao Assis, MSc
Global Technical Marketing Manager
BASF Pharma Solutions

Bailey Risteen, PhD
Global Sustainability Manager, BASF Pharma Solutions
BASF Pharma Solutions

Sebastien Taillemite
President
Ecovamed

Will Clark
Senior Director, CMC Sustainability
GSK

Lindsay Johnson, PhD
Global Technical Marketing Manager
BASF Pharma Solutions

Register Free: https://www.pharmtech.com/pt_w/emerging-trends

Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content

Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration | Image Credit: © LASZLO - stock.adobe.com

CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib

Patrick Lavery
May 21st 2025
Article

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


IRVINE, CALIFORNIA - 16 APRIL 2020: Student Center and Visitor Center Building on the campus of the University of California Irvine, UCI. | Image Credit: © Steve Cukrov - stock.adobe.com

UC Irvine Lab Studies NLRP3 Inflammasome for Inflammatory Disease Treatment Potential

Patrick Lavery
May 19th 2025
Article

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Pharmacy, hands and prescription medicine for customer with paper bag for healthcare, drugs and pharmaceutical. Closeup of a pharmacist or medical worker with person in drugstore for retail service | Image Credit: © Azee Jacobs/peopleimages.com - stock.adobe.com

Trump Issues Executive Order Aimed at Reducing Prescription Drug Prices for US Patients

Patrick Lavery
May 13th 2025
Article

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.


Feb 2, 2020 South San Francisco / CA / USA - Genentech headquarters in Silicon Valley; Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009 | Image Credit: © Sundry Photography - stock.adobe.com

Genentech and Roche Expand US Footprint with New North Carolina Manufacturing Facility

Patrick Lavery
May 13th 2025
Article

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Related Content

Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration | Image Credit: © LASZLO - stock.adobe.com

CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib

Patrick Lavery
May 21st 2025
Article

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


IRVINE, CALIFORNIA - 16 APRIL 2020: Student Center and Visitor Center Building on the campus of the University of California Irvine, UCI. | Image Credit: © Steve Cukrov - stock.adobe.com

UC Irvine Lab Studies NLRP3 Inflammasome for Inflammatory Disease Treatment Potential

Patrick Lavery
May 19th 2025
Article

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Pharmacy, hands and prescription medicine for customer with paper bag for healthcare, drugs and pharmaceutical. Closeup of a pharmacist or medical worker with person in drugstore for retail service | Image Credit: © Azee Jacobs/peopleimages.com - stock.adobe.com

Trump Issues Executive Order Aimed at Reducing Prescription Drug Prices for US Patients

Patrick Lavery
May 13th 2025
Article

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.


Feb 2, 2020 South San Francisco / CA / USA - Genentech headquarters in Silicon Valley; Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009 | Image Credit: © Sundry Photography - stock.adobe.com

Genentech and Roche Expand US Footprint with New North Carolina Manufacturing Facility

Patrick Lavery
May 13th 2025
Article

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.